TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

被引:14
|
作者
Riku, Yuichi [1 ,2 ]
Yoshida, Mari [1 ]
Iwasaki, Yasushi [1 ]
Sobue, Gen [3 ]
Katsuno, Masahisa [2 ,4 ]
Ishigaki, Shinsuke [5 ]
机构
[1] Aichi Med Univ, Inst Med Sci Aging, Nagakute 4801195, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya 7448550, Japan
[3] Aichi Med Univ, Grad Sch Med, Nagakute 4801195, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Clin Res Educ, Nagoya 7448550, Japan
[5] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu 5202192, Japan
基金
日本学术振兴会; 英国科研创新办公室;
关键词
AD; ALS; CBD; FTLD; LATE; PART; PSP; TDP-43; SFPQ; tau; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE SUPRANUCLEAR PALSY; GRANULOVACUOLAR DEGENERATION; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; TAU PATHOLOGY; MOUSE MODEL; NEUROPATHOLOGICAL CRITERIA;
D O I
10.3390/ijms232415755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transactivation response DNA binding protein 43 kDa (TDP-43) and tau are major pathological proteins of neurodegenerative disorders, of which neuronal and glial aggregates are pathological hallmarks. Interestingly, accumulating evidence from neuropathological studies has shown that comorbid TDP-43 pathology is observed in a subset of patients with tauopathies, and vice versa. The concomitant pathology often spreads in a disease-specific manner and has morphological characteristics in each primary disorder. The findings from translational studies have suggested that comorbid TDP-43 or tau pathology has clinical impacts and that the comorbid pathology is not a bystander, but a part of the disease process. Shared genetic risk factors or molecular abnormalities between TDP-43 proteinopathies and tauopathies, and direct interactions between TDP-43 and tau aggregates, have been reported. Further investigations to clarify the pathogenetic factors that are shared by a broad spectrum of neurodegenerative disorders will establish key therapeutic targets.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] What to do with unusual TDP-43 proteinopathy cases?
    Nelson, Peter T.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (01)
  • [22] Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications
    Liu, Yu-Chih
    Chiang, Po-Min
    Tsai, Kuen-Jer
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (10) : 20079 - 20111
  • [24] ALS and FTLD: two faces of TDP-43 proteinopathy
    Liscic, R. M.
    Grinberg, L. T.
    Zidar, J.
    Gitcho, M. A.
    Cairns, N. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) : 772 - 780
  • [25] Significance and limitation of the pathological classification of TDP-43 proteinopathy
    Arai, Tetsuaki
    NEUROPATHOLOGY, 2014, 34 (06) : 578 - 588
  • [26] Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Tsuji, Hiroshi
    Arai, Tetsuaki
    Kametani, Fuyuki
    Nonaka, Takashi
    Yamashita, Makiko
    Suzukake, Masami
    Hosokawa, Masato
    Yoshida, Mari
    Hatsuta, Hiroyuki
    Takao, Masaki
    Saito, Yuko
    Murayama, Shigeo
    Akiyama, Haruhiko
    Hasegawa, Masato
    Mann, David M. A.
    Tamaoka, Akira
    BRAIN, 2012, 135 : 3380 - 3391
  • [27] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Hayes, Lindsey R.
    Kalab, Petr
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1061 - 1084
  • [28] TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy
    McKee, Ann C.
    Gavett, Brandon E.
    Stern, Robert A.
    Nowinski, Christopher J.
    Cantu, Robert C.
    Kowall, Neil W.
    Perl, Daniel P.
    Hedley-Whyte, E. Tessa
    Price, Bruce
    Sullivan, Chris
    Morin, Peter
    Lee, Hyo-Soon
    Kubilus, Caroline A.
    Daneshvar, Daniel H.
    Wulff, Megan
    Budson, Andrew E.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (09) : 918 - 929
  • [29] Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
    Tania F. Gendron
    Leonard Petrucelli
    Journal of Molecular Neuroscience, 2011, 45 : 486 - 499
  • [30] FTLD/ALS-linked TDP-43 mutations do not alter TDP-43's ability to self-regulate its expression in Drosophila
    Miguel, Laetitia
    Avequin, Tracey
    Pons, Marine
    Frebourg, Thierry
    Campion, Dominique
    Lecourtois, Magalie
    BRAIN RESEARCH, 2018, 1695 : 1 - 9